Cyfuse Biomedical
Tokyo
About Cyfuse Biomedical
Cyfuse Biomedical develops tissue fabrication systems and cell-based products in Japan and internationally. The company offers 3D BioFabrication systems and related consumables; develops and licenses 3D tissue products for therapeutic and drug development use; and engages in contract manufacturing of 3D tissue products for research purposes. Its products applications include blood vessel grafts for blood access of hemodialysis patients or coronary artery bypass grafts; cardiac grafts for drug toxicology screening or supplemental therapy of myocardial infarction; cartilage grafts for plastic surgery or reconstruction; and hepatocyte grafts for drug metabolism screening or in-vivo production of clotting factors in the treatment of hemophilia. Cyfuse Biomedical was founded in 2010 and is based in Tokyo, Japan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $29.8M
- Last round: Series Unknown (Jan 2021)
- Website: cyfusebio.com
- Phone: +81 344557872
Industries & Categories
Health Care, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cyfuse-biomedical-38778 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.